August 18, 2022 Bayer supports demining in Ukraine with donation to non-profit “Fondation suisse de déminage”Read more
August 11, 2022 Bayer Showcases Leadership in Breakthrough Innovations and Sustainable, Tailored Solutions to Meet Global Challenges in AgricultureRead more
SPECIALIZED PRESS August 8, 2022 Not intended for U.S. and UK MediaU.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)Read more
August 2, 2022 Bayer Consumer Health leaders propose new principles for science-led self-careRead more
August 1, 2022 Bayer expands existing investment to acquire majority share in sustainable lower carbon oilseed producer CoverCress Inc.Read more
SPECIALIZED PRESS July 28, 2022 Not intended for U.S. and UK MediaPhase 2b studies of investigational selective coagulation modulators fesomersen and osocimab in patients with advanced renal disease completedRead more
SPECIALIZED PRESS July 14, 2022 Not intended for U.S. and UK MediaBayer to sell men’s health product Nebido™ to GrünenthalRead more
SPECIALIZED PRESS July 11, 2022 Not intended for U.S. and UK Media – 2022 European Congress of Radiology:Bayer to present new data from the company’s growing radiology portfolioRead more
.jpg)
